• Home
  • Features
  • Pricing
  • Docs
  • Announcements
  • Sign In

pirl-unc / hitlist / 27078597970
80%

Build:
DEFAULT BRANCH: main
Ran 07 Jun 2026 01:03AM UTC
Jobs 1
Files 29
Run time 1min
Badge
Embed ▾
README BADGES
x

If you need to use a raster PNG badge, change the '.svg' to '.png' in the link

Markdown

Textile

RDoc

HTML

Rst

07 Jun 2026 12:58AM UTC coverage: 80.371%. Remained the same
27078597970

push

github

web-flow
v1.31.2: curate 3 more cell-line immunopeptidome PMIDs (#33b/#35 batch 2) (#279)

Three paper-verified cell-line studies; HLA typing taken from IEDB's
recorded mhc_restriction in our corpus, study type verified per paper:

- 28649982 Kaur 2017 — HLA-C*05:01 + C*07:02 as separate mono-allelic
  721.221 transfectants (HLA-C expression-diversity study)
- 33537174 Shinkawa 2021 — HCT-15/b2m MSI colorectal carcinoma line
  (multi-allele endogenous typing; override cell_line/cancer)
- 26768311 Spencer 2015 — HeLa self-peptidome before/after vaccinia
  (VACV) infection; 2 ms_samples (uninfected + VACV), 5 HLA-I allotypes

22544926 (Thommen 2012) deferred — primary endothelial cells + syngeneic
B-LCL (donor study), needs full-text per-sample typing.

All classify as cell_line (Kaur mono-allelic 721.221; HCT-15/HeLa
multi-allele cancer lines). Tests + build smoke green.

5065 of 6302 relevant lines covered (80.37%)

0.8 hits per line

Jobs
ID Job ID Ran Files Coverage
1 27078597970.1 07 Jun 2026 01:03AM UTC 29
80.37
GitHub Action Run
Source Files on build 27078597970
  • Tree
  • List 29
  • Changed 0
  • Source Changed 0
  • Coverage Changed 0
Coverage ∆ File Lines Relevant Covered Missed Hits/Line
  • Back to Repo
  • Github Actions Build #27078597970
  • 6f394527 on github
  • Prev Build on main (#27078111285)
  • Next Build on main (#27080187832)
  • Delete
STATUS · Troubleshooting · Open an Issue · Sales · Support · CAREERS · ENTERPRISE · START FREE · SCHEDULE DEMO
ANNOUNCEMENTS · TWITTER · TOS & SLA · Supported CI Services · What's a CI service? · Automated Testing

© 2026 Coveralls, Inc